Inventor profile of:

Aaron Dodd

City:

Centennial Park

Country:

Australia

Published Applications:

50

Last publication date:

2026-02-26

Top Assignees for applications by Aaron Dodd

The entities that hold a legal rights for patent applications filed by inventor Dodd Aaron:

Recent patent applications by Dodd Aaron

Aaron Dodd from Centennial Park, AU has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-26
US20260054267A1
Performing operations; transporting

PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE

#2 | 2023-11-09
US20230356232A1
Performing operations; transporting

PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE

#3 | 2023-05-04
US20230133244A1
Human necessities

Method for the Production of Commercial Nanoparticle and Microparticle Powders

#4 | 2023-04-27
US20230128622A1
Chemistry; metallurgy

NOVEL FORMULATION OF MELOXICAM

#5 | 2021-12-30
US20210403442A1
Chemistry; metallurgy

Novel formulation of metaxalone

#6 | 2021-08-26
US20210260598A1
Performing operations; transporting

PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE

#7 | 2021-01-07
US20210002267A1
Chemistry; metallurgy

NOVEL FORMULATION OF MELOXICAM

#8 | 2020-12-17
US20200390710A1
Human necessities

Method for the Production of Commercial Nanoparticle and Microparticle Powders

#9 | 2020-10-01
US20200308123A1
Chemistry; metallurgy

Novel formulation of metaxalone

#10 | 2019-06-27
US20190193085A1
Performing operations; transporting

PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE

#11 | 2018-10-18
US20180296514A1
Human necessities

NOVEL FORMULATION OF DICLOFENAC

#12 | 2018-09-06
US20180251433A1
Chemistry; metallurgy

Novel formulation of metaxalone

#13 | 2018-07-12
US20180194759A1
Chemistry; metallurgy

NOVEL FORMULATION OF MELOXICAM

#14 | 2018-06-21
US20180169662A1
Performing operations; transporting

PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE

#15 | 2018-05-03
US20180117008A1
Human necessities

Formulation of indomethacin

#16 | 2018-01-11
US20180009769A1
Chemistry; metallurgy

Novel formulation of metaxalone

#17 | 2017-06-15
US20170165203A1
Human necessities

Method for the Production of Commercial Nanoparticle and Microparticle Powders

#18 | 2017-04-13
US20170100356A1
Human necessities

NOVEL FORMULATION OF DICLOFENAC

#19 | 2017-04-06
US20170095448A1
Human necessities

Formulation of indomethacin

#20 | 2016-08-04
US20160220518A1
Human necessities

Novel Formulation of Naproxen

#21 | 2016-04-21
US20160108009A1
Chemistry; metallurgy

Novel formulation of metaxalone

#22 | 2016-04-14
US20160102086A1
Chemistry; metallurgy

NOVEL FORMULATION OF MELOXICAM

#23 | 2016-03-10
US20160067199A1
Human necessities

NOVEL FORMULATION OF DICLOFENAC

#24 | 2016-03-03
US20160058707A1
Human necessities

NOVEL FORMULATION OF DICLOFENAC

#25 | 2016-01-28
US20160022637A1
Human necessities

Formulation of indomethacin

#26 | 2015-11-05
US20150313857A1
Human necessities

Novel Formulation of Naproxen

#27 | 2015-07-30
US20150209796A1
Performing operations; transporting

PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE

#28 | 2015-06-11
US20150157573A1
Human necessities

Formulation of diclofenac

#29 | 2015-06-04
US20150150824A1
Human necessities

Formulation of diclofenac

#30 | 2015-06-04
US20150150823A1
Human necessities

Formulation of diclofenac

#31 | 2015-06-04
US20150150805A1
Human necessities

Formulation of diclofenac

#32 | 2015-03-26
US20150087709A1
Human necessities

Novel Formulation of Naproxen

#33 | 2014-11-06
US20140326812A1
Performing operations; transporting

Method for the Production of Commercial Nanoparticle and Microparticle Powders

#34 | 2014-10-09
US20140302127A1
Human necessities

Novel formulation of metaxalone

#35 | 2014-09-11
US20140256781A1
Human necessities

Formulation of indomethacin

#36 | 2014-09-11
US20140255494A1
Human necessities

Formulation of indomethacin

#37 | 2014-09-04
US20140248359A1
Human necessities

Formulation of diclofenac

#38 | 2014-08-07
US20140220121A1
Human necessities

Formulation of diclofenac

#39 | 2014-07-17
US20140200276A1
Human necessities

NOVEL FORMULATION OF NAPROXEN

#40 | 2014-07-17
US20140199395A1
Human necessities

NOVEL FORMULATION OF MELOXICAM

#41 | 2014-07-10
US20140194487A1
Human necessities

Formulation of indomethacin

#42 | 2012-10-18
US20120263760A1
Chemistry; metallurgy

NOVEL FORMULATION OF METAXALONE

#43 | 2012-08-09
US20120202694A1
Performing operations; transporting

PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE

#44 | 2012-06-28
US20120165410A1
Performing operations; transporting

PRODUCTION OF ENCAPSULATED NANOPARTICLES AT HIGH VOLUME FRACTIONS

#45 | 2012-06-28
US20120165323A1
Human necessities

METHOD FOR IMPROVING THE DISSOLUTION PROFILE OF A BIOLOGICALLY ACTIVE MATERIAL

#46 | 2012-06-28
US20120160944A1
Human necessities

METHOD FOR THE PRODUCTION OF COMMERCIAL NANOPARTICLE AND MICRO PARTICLE POWDERS

#47 | 2012-06-14
US20120148634A1
Human necessities

NOVEL FORMULATION OF NAPROXEN

#48 | 2012-06-07
US20120141548A1
Chemistry; metallurgy

NOVEL FORMULATION OF MELOXICAM

#49 | 2012-05-31
US20120135048A1
Human necessities

NOVEL FORMULATION OF INDOMETHACIN

#50 | 2012-05-31
US20120135047A1
Human necessities

Formulation of diclofenac

InventorID:

833305 ⎘